

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding and managing... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/5-2052/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/5-2052" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding and managing asthma" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding and managing asthma.">
            <meta name="og:description" content="Read the latest article version by Su-Ling Loo, Peter A.B. Wark, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="9940">
            <meta name="article-id" content="9236">
            <meta name="dc.title" content="Recent advances in understanding and managing asthma">
            <meta name="dc.description" content="This review highlights the important articles published in the area of asthma research from January 2015 to July 2016. In basic science, significant advances have been made in understanding the link between the innate immune response and type II acquired immune responses in asthma and the role of the airway epithelium. Novel information continues to emerge with regard to the pathogenesis and heterogeneity of severe asthma. There have been important translational clinical trials in the areas of childhood asthma, treatment of allergy to improve asthma outcomes, and improving drug delivery to optimize the management of asthma. In addition, there are increasing data concerning the application of biological agents to the management of severe asthma. This body of work discusses the most notable advances in the understanding and management of asthma.">
            <meta name="dc.subject" content="asthma, childhood asthma, understanding and treatment of asthma ">
            <meta name="dc.creator" content="Loo, Su-Ling">
            <meta name="dc.creator" content="Wark, Peter A.B.">
            <meta name="dc.date" content="2016/08/23">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.9236.1">
            <meta name="dc.source" content="F1000Research 2016 5:2052">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="asthma">
            <meta name="prism.keyword" content=" childhood asthma">
            <meta name="prism.keyword" content=" understanding and treatment of asthma ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2016/08/23">
            <meta name="prism.volume" content="5">
            <meta name="prism.number" content="2052">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.9236.1">
            <meta name="prism.url" content="https://f1000research.com/articles/5-2052">
            <meta name="citation_title" content="Recent advances in understanding and managing asthma">
            <meta name="citation_abstract" content="This review highlights the important articles published in the area of asthma research from January 2015 to July 2016. In basic science, significant advances have been made in understanding the link between the innate immune response and type II acquired immune responses in asthma and the role of the airway epithelium. Novel information continues to emerge with regard to the pathogenesis and heterogeneity of severe asthma. There have been important translational clinical trials in the areas of childhood asthma, treatment of allergy to improve asthma outcomes, and improving drug delivery to optimize the management of asthma. In addition, there are increasing data concerning the application of biological agents to the management of severe asthma. This body of work discusses the most notable advances in the understanding and management of asthma.">
            <meta name="citation_description" content="This review highlights the important articles published in the area of asthma research from January 2015 to July 2016. In basic science, significant advances have been made in understanding the link between the innate immune response and type II acquired immune responses in asthma and the role of the airway epithelium. Novel information continues to emerge with regard to the pathogenesis and heterogeneity of severe asthma. There have been important translational clinical trials in the areas of childhood asthma, treatment of allergy to improve asthma outcomes, and improving drug delivery to optimize the management of asthma. In addition, there are increasing data concerning the application of biological agents to the management of severe asthma. This body of work discusses the most notable advances in the understanding and management of asthma.">
            <meta name="citation_keywords" content="asthma, childhood asthma, understanding and treatment of asthma ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Su-Ling Loo">
            <meta name="citation_author_institution" content="Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, New Lambton, NSW, 2305, Australia">
            <meta name="citation_author" content="Peter A.B. Wark">
            <meta name="citation_author_institution" content="Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, New Lambton, NSW, 2305, Australia">
            <meta name="citation_publication_date" content="2016/08/23">
            <meta name="citation_volume" content="5">
            <meta name="citation_publication_number" content="2052">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.9236.1">
            <meta name="citation_firstpage" content="2052">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/5-2052/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/5-2052.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=9940 /> <input type=hidden id=articleId name=articleId value=9236 /> <input type=hidden id=xmlUrl value="/articles/5-2052/v1/xml"/> <input type=hidden id=xmlFileName value="-5-2052-v1.xml"> <input type=hidden id=article_uuid value=4ea0b20c-b74f-4b99-8489-8a9f7b13f8e3 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding and managing asthma"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.9236.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.9236.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/5-2052"
  },
  "headline": "Recent advances in understanding and managing asthma",
  "datePublished": "2016-08-23T16:07:06",
  "dateModified": "2016-08-23T16:07:06",
  "author": [
    {
      "@type": "Person",
      "name": "Su-Ling Loo"
    },    {
      "@type": "Person",
      "name": "Peter A.B. Wark"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "This review highlights the important articles published in the area of asthma research from January 2015 to July 2016. In basic science, significant advances have been made in understanding the link between the innate immune response and type II acquired immune responses in asthma and the role of the airway epithelium. Novel information continues to emerge with regard to the pathogenesis and heterogeneity of severe asthma. There have been important translational clinical trials in the areas of childhood asthma, treatment of allergy to improve asthma outcomes, and improving drug delivery to optimize the management of asthma. In addition, there are increasing data concerning the application of biological agents to the management of severe asthma. This body of work discusses the most notable advances in the understanding and management of asthma."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/5-2052.html",
            "name": "Recent advances in understanding and managing asthma"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding and managing asthma </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=9940 data-id=9236 data-downloads="" data-views="" data-scholar="10.12688/f1000research.9236.1" data-recommended="" data-doi="10.12688/f1000research.9236.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/5-2052/v1/pdf?article_uuid=4ea0b20c-b74f-4b99-8489-8a9f7b13f8e3" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-9236-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-9236-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-9236-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Loo SL and Wark PAB. Recent advances in understanding and managing asthma [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):2052 (<a class=new-orange href="https://doi.org/10.12688/f1000research.9236.1" target=_blank>https://doi.org/10.12688/f1000research.9236.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-9236-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=9236 id=track-article-signin-9236 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/9236?target=/articles/5-2052.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=9940 /> <input name=articleId type=hidden value=9236 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding and managing asthma</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Su-Ling Loo,&nbsp;</span><span class=""><a href="mailto:Peter.Wark@hnehealth.nsw.gov.au" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Peter A.B. Wark</span></a></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Su-Ling Loo,&nbsp;</span><span class=""><a href="mailto:Peter.Wark@hnehealth.nsw.gov.au" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Peter A.B. Wark</span></a></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 23 Aug 2016 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.9236.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, New Lambton, NSW, 2305, Australia<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=13232-15840></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=16684-15841></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> This review highlights the important articles published in the area of asthma research from January 2015 to July 2016. In basic science, significant advances have been made in understanding the link between the innate immune response and type II acquired immune responses in asthma and the role of the airway epithelium. Novel information continues to emerge with regard to the pathogenesis and heterogeneity of severe asthma. There have been important translational clinical trials in the areas of childhood asthma, treatment of allergy to improve asthma outcomes, and improving drug delivery to optimize the management of asthma. In addition, there are increasing data concerning the application of biological agents to the management of severe asthma. This body of work discusses the most notable advances in the understanding and management of asthma. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> asthma, childhood asthma, understanding and treatment of asthma </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Peter A.B. Wark (<a href="mailto:Peter.Wark@hnehealth.nsw.gov.au">Peter.Wark@hnehealth.nsw.gov.au</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Peter A.B. Wark </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2016 Loo SL and Wark PAB. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Loo SL and Wark PAB. Recent advances in understanding and managing asthma [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):2052 (<a href="https://doi.org/10.12688/f1000research.9236.1" target=_blank>https://doi.org/10.12688/f1000research.9236.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 23 Aug 2016, <b>5</b>(F1000 Faculty Rev):2052 (<a href="https://doi.org/10.12688/f1000research.9236.1" target=_blank>https://doi.org/10.12688/f1000research.9236.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 23 Aug 2016, <b>5</b>(F1000 Faculty Rev):2052 (<a href="https://doi.org/10.12688/f1000research.9236.1" target=_blank>https://doi.org/10.12688/f1000research.9236.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d37704e155>Introduction</h2><p class="" id=d37704e158>In recent years, there have been major advances in the understanding and treatment of asthma. A greater understanding of the mechanisms of disease through basic science research over the last twenty years has resulted in the development of highly specific treatments that better target the dysregulated immune processes behind asthma and now are being translated into new effective disease-modifying treatments. At the same time, translational clinical research has opened our eyes to the diverse biology of asthma and is starting to lead investigators towards mechanisms that are not confined to allergic and type II immune responses to meet the needs of greater numbers of asthma sufferers. These changes have made for an exciting time in asthma research, with a large increase in novel interventions going into clinical trials. This article will review selected important articles that have been published in the literature from January 2015 to July 2016 in the fields of basic science leading to better understanding of the mechanisms behind asthma, as well as important or potentially important clinical trials that may transform its management.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d37704e164>Interferon responses in asthma</h2><p class="" id=d37704e167>Viral respiratory tract infections are the most common triggers of acute asthma in children<sup><a href="#ref-1">1</a></sup> and adults<sup><a href="#ref-2">2</a></sup>. Asthmatics, while not more prone to viral infections, have more severe symptoms and these infections trigger exacerbations of asthma and periods of worsened control<sup><a href="#ref-3">3</a></sup>. Given this observed susceptibility to the effects of viral infections, it has been proposed that asthmatics, by reasons of genetics or acquired factors, have a defect in antiviral immunity. Interferons (IFNs) play a central role in host immune responses to viral infections. The airway epithelium releases IFNs in response to viruses as part of the initial innate immune response to infection. They induce IFN-stimulated genes and lead to the production of antiviral proteins<sup><a href="#ref-4">4</a></sup>. IFNs consist of type I (IFN-α/-β), type II (IFN-γ), and type III (IFN-λ1, 2, and 3)<sup><a href="#ref-5">5</a></sup>. The impaired IFN response in asthmatics remains a contentious issue in the literature. We originally demonstrated<sup><a href="#ref-6">6</a></sup> that rhinovirus-16 (RV-16) replication was increased in asthmatic bronchial epithelial cells (BECs) compared to healthy controls. This was due to an impairment in IFN-β, and when exogenous IFN-β was added to cultures, apoptosis was induced and viral replication reduced. This was later confirmed by Cakebread <i>et al.</i><sup><a href="#ref-7">7</a></sup>, who showed that the expression of IFN-β-stimulated anti-viral genes was comparable in primary BECs from asthmatics and non-asthmatics. They suggested that IFN-β was able to reduce the expression of inflammatory cytokines such as CXCL-10, RANTES, and interleukin (IL)-6, suggesting that IFN-β may shorten the duration of inflammatory responses.</p><p class="" id=d37704e201>This was extended to type III IFN-λ by Contoli <i>et al.</i>, who found that asthmatic BECs were deficient in the induction of IFN-λ. This correlated with RV-induced asthma exacerbations and viral load in experimentally infected human volunteers<sup><a href="#ref-5">5</a></sup>. This deficiency in IFN-λ in primary BECs was again demonstrated by Parsons <i>et al.</i> They showed that this was due not to deficient expression of MDA5 and Toll-like receptor 3 (TLR3) but to an inability to later activate types I and III IFN immune responses to RV infection<sup><a href="#ref-8">8</a></sup>. These deficient innate responses were also demonstrated in children who were asthmatic regardless of their atopic status and in atopic patients without asthma by Baraldo <i>et al.</i><sup><a href="#ref-9">9</a></sup>. However, other studies have found no change in IFN-β<sup><a href="#ref-10">10</a></sup> or λ<sup><a href="#ref-11">11</a></sup> in the asthmatic epithelium.</p><p class="" id=d37704e233>Investigating this process further, Kicic <i>et al.</i> recently found that BECs from asthmatic children had reduced IFN-β release and increased inflammatory cytokine production compared to healthy control cells. Exogenous IFN-β restored apoptosis, suppressed viral replication, and improved wound healing but did not reduce the heightened inflammatory cytokine production<sup><a href="#ref-12">12</a></sup>.</p><p class="" id=d37704e243>Deficient IFN responses and susceptibility to viral infection may be present in only some asthmatics, reflecting either airway pathology or the severity of disease. Simpson <i>et al.</i><sup><a href="#ref-13">13</a></sup> assessed the response of peripheral blood monocytes (PBMCs) to exposure to a single strain of RV from 86 adults with poorly controlled asthma despite treatment with moderate- to high-dose inhaled corticosteroids (ICS). They found that those who demonstrated impaired PBMC release of IFN-α to RV-1B had elevated airway neutrophils and were on the highest doses of ICS. Responses to infection then may vary depending on the characteristics of asthmatic inflammation, and there is the implication that treatment with high doses of ICS may increase susceptibility to viral infection in asthma. This is an area of great interest and could have significant implications for individually tailored IFN augmentation treatments.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d37704e255>Type II immune inflammation and impaired interferon responses</h2><p class="" id=d37704e258>Dysregulated type II immune responses are seen in a large proportion of asthmatics, especially those with childhood-onset disease. The mechanisms of impaired IFN responses and how they relate to the type II inflammatory responses typically seen in asthmatics is also of considerable interest in the current literature.</p><p class="" id=d37704e261>Contoli <i>et al.</i><sup><a href="#ref-14">14</a></sup> recently evaluated the effects of two archetypal type II immune cytokines, IL-4 and IL-13, on innate immune responses by BECs in response to RV infection. Human BECs were pre-treated with IL-4 and IL-13 for 24 hours and this led to impaired RV-16-induced activation of IRF3 and inhibited TLR3, resulting in a significant dose-dependent inhibition of IFN-β release 8 hours after infection. This resulted in increased RV replication in the cultures<sup><a href="#ref-14">14</a></sup>. This study demonstrates that a type II immune cytokine environment alone is sufficient to dampen innate immune responses in BECs.</p><p class="" id=d37704e274>Similar studies looking at double-stranded RNA (dsRNA) have had mixed findings. IL-13 was implicated to impair the production of dsRNA-induced IFN-λ expression from BECs<sup><a href="#ref-15">15</a></sup>. In contrast, Herbert <i>et al.</i> found that although IL-4 and IL-13 could promote pro-inflammatory cytokines by BECs in response to dsRNA, anti-viral host defenses in asthmatics were not impaired<sup><a href="#ref-16">16</a></sup>.</p><p class="" id=d37704e288>IL-4, IL-13, and RV infection were also able to induce suppressor of cytokine signaling 1 (SOCS1) expression. It was found that SOCS1 protein expression was increased in the airway epithelium from asthmatic adults measured in bronchial biopsy specimens, and the presence of SOCS1 correlated with a greater severity of atopy and airway hyper-responsiveness<sup><a href="#ref-17">17</a></sup>. The overexpression of SOCS1 in both primary BECs and a human epithelial cell line completely inhibited exogenous IFN-β-induced activation of both the IFN-β and the IFN-λ promoters. This overexpression also suppressed RV-induced IFN promoter activation in primary BECs and significantly increased IL-1β- and TNF-α-induced CXCL8. Therefore, increased levels of SOCS1 were shown to impair IFN induction in asthmatic patients through its nuclear localization, but this was specific for only antiviral immunity, as inflammatory mediators were not affected. This is a novel study revealing a possible mechanism for impaired IFN responses in asthmatics.</p><p class="" id=d37704e296>Jackson <i>et al.</i> showed that IL-33 and type II cytokines IL-4, IL-5, and IL-13 were induced by RV in the asthmatic airway <i>in vivo</i> and that these levels related to exacerbation severity. IL-33 was strongly induced by RV infection of primary bronchial cells <i>in vitro</i>. The supernatant from RV-infected human BECs was able to induce type II cytokine production by human T cells and type II innate lymphoid cells<sup><a href="#ref-18">18</a></sup>.</p><p class="" id=d37704e312>IL-33 has also been suggested as a link between innate immune activation and type II immune responses in asthma. In the airways of mild steroid-naïve asthmatics, IL-33 mRNA expression was also associated with increased TLR2 and TLR4 expression as well as allergic sensitization to house dust mite (HDM) and elevated levels of fractional exhaled nitric oxide (FeNO)<sup><a href="#ref-19">19</a></sup>. In mice, Tashiro <i>et al.</i> showed that IL-33 levels in lung homogenates were markedly increased in HDM-sensitized mice compared to control mice and that IL-33 levels were increased in mononuclear cells derived from the lungs of HDM-sensitized mice compared to controls<sup><a href="#ref-20">20</a></sup>.</p><p class="" id=d37704e326>Another emerging and important link between activation of the innate immune response in asthma and acquired type II immune responses that are driven by T helper type 2 (TH2) cells are innate lymphoid cells (ILCs). These are non-T, non-B lymphocytes that can be activated rapidly in response to external stimuli without the need for a specific antigen–antibody interaction. They are defined based on the types of cytokines they produce, those associated with asthma and allergic disease, release IL-5, IL-9, and IL-13, and are termed ILC2s. Activated by thymic stromal lymphopoietin (TSLP), IL-33, and IL-25, ILC2s release large amounts of type II cytokines leading to increased inflammation, recruitment of eosinophils to the airways, and airway hyperresponsiveness<sup><a href="#ref-21">21</a>–<a href="#ref-23">23</a></sup>.</p><p class="" id=d37704e336>The role for ILC2s in asthma is currently under intense investigation. In a pioneering study, Duerr <i>et al.</i><sup><a href="#ref-24">24</a></sup> demonstrated that type I IFNs reduced the capacity of IL-33-stimulated mouse and human ILC2s to proliferate and release type II cytokines IL-4, IL-5, IL-9, and IL-13 as well as the pro-inflammatory cytokines IL-6 and granulocyte macrophage colony-stimulating factor (GM-CSF). Type I IFN receptor-deficient mice had increased numbers of ILC2s and enhanced type II immune responses upon infection. Type I IFNs directly and negatively regulated mouse and human ILC2s dependent on the transcriptional activator IFN-stimulated gene factor 3 (ISGF3) that led to reduced type II cytokine production, cell proliferation, and increased cell death<sup><a href="#ref-24">24</a></sup>.</p><p class="" id=d37704e349>In turn, Lynch <i>et al.</i> used a mouse model using pneumonia virus of mice (PVM) and low-dose cockroach extract (CRE) to induce the features of allergic asthma and acute viral infection. CRE exposure during viral infection in early life induced IL-33, which suppressed IFN-α and IFN-λ production, increasing type II inflammation and the viral burden. This was shown to be through the downregulation of viperin and IRAK1 in plasmacytoid dendritic cells <i>in vivo</i> and <i>in vitro</i>, leading to a state of TLR7 hyper-responsiveness<sup><a href="#ref-25">25</a></sup>.</p><p class="" id=d37704e365>While overall very few in number, elevated numbers of ILC2s have been previously found in the peripheral blood of allergic asthmatics. Investigators from Shanghai set out to determine if IL-13<sup>+</sup> ILC2s correlated with asthma severity<sup><a href="#ref-26">26</a></sup>. ILC2s were identified by flow cytometry as a distinct CD45hi IL-7Rα<sup>+</sup> CRTH2<sup>+</sup> cell population from human PBMCs. The investigators found that the frequencies of ILC2s were increased in asthmatics (0.04±0.02%) compared to healthy subjects (0.025±0.011%) and the percentages of IL-13<sup>+</sup> ILC2s were significantly higher in subjects with uncontrolled asthma (49.7±16.9%) and partly controlled groups (30.8±13.1%) compared to the well-controlled group (16.7±5.9%) and healthy controls (18.7±8.7%). Effective clinical treatment of uncontrolled IL-13<sup>+</sup> ILC2-positive asthmatics resulted in dynamic modulation of IL-13<sup>+</sup> ILC2 levels back to baseline. ILC2s were strongly stimulated by IL-25/-33 and, interestingly, when the investigators pretreated cells with dexamethasone, they found ILC2s were more resistant to suppression than TH2 cells <i>in vitro</i><sup><a href="#ref-26">26</a></sup>.</p><p class="" id=d37704e398>These studies provide exciting links between innate anti-viral responses and the type II cytokine inflammatory conditions seen in asthma and are summarized in <a href="#f1">Figure 1</a>. If a type II cytokine environment suppresses IFN responses, and IFN responses are able to suppress ILC2s, then in asthma there could be a positive cycle feeding into an exaggerated pro-inflammatory cytokine response, as well as a perpetuation of viral replication. This could provide insights into what happens during a viral infection and exacerbations leading to worsened asthmatic inflammation.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/9940/9e535df7-c6ab-4875-9cdf-5c1fdd96ad6a_figure1.gif"><img alt="9e535df7-c6ab-4875-9cdf-5c1fdd96ad6a_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/9940/9e535df7-c6ab-4875-9cdf-5c1fdd96ad6a_figure1.gif"></a><div class=caption><h3>Figure 1. Interactions between the type II immune cytokine environment and interferon responses in the asthmatic airway during rhinovirus infection.</h3><p id=d37704e414>The asthmatic airway is suggested to be deficient in the production of interferons in response to rhinovirus infection. This contributes to increased viral replication. The type II immune cytokines interleukin (IL)-4 and IL-13 have been shown to dampen interferon responses, possibly through the induction of suppressor of cytokine signaling 1 (SOCS1). IL-33 is induced by rhinovirus infection and activates type 2 innate lymphoid cells (ILC2s), which in turn release type II cytokines and pro-inflammatory cytokines such as IL-6 and granulocyte macrophage colony-stimulating factor (GM-CSF). Recent findings demonstrate the ability of type I interferons to suppress IL-33-stimulated ILC2 responses.</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d37704e424>The role of the airway epithelium in asthma</h2><p class="" id=d37704e427>BECs have been recognized as having an important contribution to the innate immune response but are thought to have a limited contribution to adaptive immune responses. Typically, TH1-derived IFN-γ inhibits TH2 cell differentiation, whereas TH2-derived IL-4 promotes TH2 differentiation. It is unknown if airway epithelial cells have the same TH1/TH2 programs as lymphocytes. BECs recognize IL-4 as well as express the receptor for its structural homolog, IL-13. Airway epithelial cells also express IFN-γ receptors. Zissler <i>et al.</i> exposed primary BECs exposed to IL-4 or IFN and then performed genome-wide transcriptome analysis. The study demonstrated an antagonistic regulation pattern of IL-4 and IFN-γ, translating the TH1/TH2 antagonism directly to epithelial gene regulation. IL-4 and IFN-γ induced separate transcription factor hubs or clusters, which are present in antagonistically and polarized gene regulation networks. Furthermore, the IL-4-dependent induction of IL-24 observed in rhinitis patients was downregulated by IFN-γ; therefore, IL-24 represents a potential unique biomarker of allergic inflammation and a TH2-polarized epithelium<sup><a href="#ref-27">27</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d37704e440>Early life asthma</h2><p class="" id=d37704e443>The prevention of asthma or modifying the risk of its development <i>in utero</i> would clearly be enormously beneficial to society and for those suffering from asthma throughout their lives. Vitamin D has long been implicated in the pathogenesis of asthma and immunity, and two important trials sought to determine if vitamin D3 supplementation could influence the development of asthma in early childhood. The first trial, which was based in Europe, recruited 623 women at 24 weeks and followed 581 children to age 3<sup><a href="#ref-28">28</a></sup>. Women were randomized to receive the usual supplement of 400 IU or vitamin D at 2400 IU, with the primary aim being that supplementation would reduce persistent wheeze at age 3 years. The intervention arm had 16% develop persistent wheeze versus 20% of controls, which was not significantly different, though other secondary outcomes such as troublesome episodes of lung problems were reduced. The second trial reported in the same journal was a larger US study in three centers and followed 806 children to age 3 but recruited women whose children were at high risk of asthma<sup><a href="#ref-29">29</a></sup>. The intervention arm received high-dose (4000 IU) vitamin D and the control arm received 400 IU. With the selection of a higher risk group, more children (218/806) developed persistent wheeze, and, while there was an absolute reduction in persistent wheeze by 6%, this also failed to reach significance. Interestingly, most of the effect appeared to occur in the first 1–2 years and then may have waned. In both studies, those who received extra supplementation were more likely to be vitamin D sufficient. The results seen in both trials were similar, and it is possible that the trials were underpowered to detect such a complex outcome, though as a consequence the case that vitamin D supplementation will modify asthma risk remains unproven.</p><p class="" id=d37704e457>The risk of developing early life asthma is complex and it has been known for some time that this risk is modified by gender, with a heightened risk in boys that switches to girls at puberty<sup><a href="#ref-30">30</a></sup>. The complexity of early life asthma was illustrated by a cross-sectional US epidemiological survey that further emphasized the importance of gender<sup><a href="#ref-31">31</a></sup>. In 1623 singleton live births that were followed by questionnaire at 6 months and then yearly until age 9, the investigators found 12.7% were early transient wheezers and 13.1% became persistent wheezers. Compared with never/infrequent wheeze, maternal asthma, infant bronchiolitis, and atopic dermatitis were associated with persistent wheeze in both sexes, but paternal asthma was associated with persistent wheeze in boys only (odds ratio [OR] 4.27; 95% confidence interval [CI] 2.33–7.83), while being black or Hispanic was a predictor for girls only. The strong association between paternal asthma and risk in boys is certainly emphasized as well as confirming the role of other previously described environmental and social factors. These studies emphasize that for boys, paternal inherited factors appear to play an important role in developing persistent asthma and what those factors are should be further investigated.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d37704e472>Sublingual dust mite immunotherapy and asthma</h2><p class="" id=d37704e475>The close association between asthma and allergy to dust mites in childhood has led to numerous interventions to reduce the impact of this exposure on asthma. The advent of sublingual immunotherapy has revised academic interest in desensitization, opening this up as a therapy to more individuals with less disruption and potentially less risk compared to subcutaneously administered protocols of desensitization. Virchow <i>et al.</i><sup><a href="#ref-32">32</a></sup> took 834 adults sensitized to HDM with asthma that was not well controlled on ICS alone. Subjects were randomized to receive either placebo or two doses of sublingual HDM; the primary outcome was a reduction in time to first moderate to severe exacerbation. Both of the doses reduced the risk of asthma exacerbation (hazard ratio 0.72; 95% CI 0.52–0.99), though there were no changes in asthma control scores or quality of life. While the effect seen was modest, it does demonstrate that chronic allergen exposure plays a direct role in exacerbation risk and, if reduced, modifies asthma.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d37704e487>Modifying exacerbations of asthma by controlling allergic disease</h2><p class="" id=d37704e490>Exacerbations of asthma in children continue to occur despite treatment and are more likely in those with more severe disease and a history of previous exacerbations<sup><a href="#ref-33">33</a></sup>. An interesting phenomenon that has been seen with these exacerbations has been a rise that occurs when children first return to school from their summer holidays that has been attributed to the combined effects of allergen exposure and the exacerbation triggered by a viral infection. An intervention that disrupts this interaction therefore could have an important effect on improving asthma care. This was proposed by Teach <i>et al.</i><sup><a href="#ref-34">34</a></sup> when they selected atopic children aged 6–17 years who had a previous history of asthma exacerbation despite regular treatment with ICS at a dose of at least 200 mcg/day fluticasone equivalence. Before the fall seasons of 2012 and 2013, 727 children were enrolled, 513 were randomized, and 478 were analyzed. Subjects received omalizumab (a monoclonal antibody against immunoglobulin E [IgE] that has been shown to reduce asthma exacerbation frequency), a boost in their ICS dose, or placebo. The fall in exacerbation rate was significantly lower in the omalizumab versus placebo arms (11.3% versus 21.0%; OR 0.48; 95% CI 0.25–0.92), but there was no significant difference between omalizumab and the ICS boost (8.4% versus 11.1%; OR 0.73; 95% CI 0.33–1.64). In a pre-specified subgroup analysis, among participants with an exacerbation during the run-in phase, omalizumab was significantly more efficacious than both placebo (6.4% versus 36.3%; OR 0.12; 95% CI 0.02–0.64) and ICS boost (2.0% versus 27.8%; OR 0.05; 95% CI 0.002–0.98). Omalizumab was also more effective in those who were defined as having more severe disease requiring treatment during the run-in phase. In an additional subgroup analysis of 87 subjects, PBMCs were taken before and after changes in treatment and the immune response in terms of IFN-α response to RV was assessed. Omalizumab improved IFN-α responses to RV, and within the omalizumab group, greater IFN-α increases were associated with fewer exacerbations (OR 0.14; 95% CI 0.01–0.88). This trial for the first time accurately identified that children with more severe disease – including a history of serious exacerbations despite regular ICS treatment – will benefit from more intense treatment of their asthma, directly reducing their susceptibility to virus-induced exacerbations of asthma.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d37704e506>The consequences of childhood asthma for lung health throughout life</h2><p class="" id=d37704e509>One of the most revealing studies to come from 2016 was the longitudinal follow-up of the childhood asthma management project (CAMP) cohort. This original study took 1041 children aged 5–12 years with chronic mild to moderate asthma and treated them for 5 years with inhaled budesonide, nedocromil, or placebo<sup><a href="#ref-35">35</a></sup>. The interventions at the time failed to influence lung function growth. A paper by McGeachie <i>et al.</i><sup><a href="#ref-36">36</a></sup> now reports on the pattern of lung function 13 years after the trial concluded in 85% of the cohort. In persons without lung disease, forced expiratory volume in 1 second (FEV1) reaches its maximal level in late adolescence or early adulthood (usually around 20 years of age) and remains stable for several years, a period known as the plateau of lung function, before gradually declining, usually after 25 years<sup><a href="#ref-37">37</a></sup>. The authors found in this group with mild to moderate asthma that 75% had abnormal lung growth and decline. Impaired lung function at enrollment and male sex were the most significant predictors of abnormal longitudinal patterns of lung function growth and decline. A pattern of reduced growth was evident early in childhood and was found to persist into early adulthood; 52% of patients had early lung function decline. By the age of 26 years, 11% of the cohort met the post-bronchodilator spirometric definition of chronic obstructive pulmonary disease (COPD). This study clearly emphasizes the enormous long-term effect childhood asthma can have on lung function throughout life. It makes the case that identifying and following those with abnormal spirometric trajectories may be important to identify those at risk of adult lung disease, though it is sobering that we still do not have an intervention that has been shown to alter these outcomes.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d37704e529>Better drug delivery improves asthma outcomes</h2><p class="" id=d37704e532>The advantage in asthma of using medications that are inhaled is that the drug can be delivered to the affected airway, the site of disease, while minimizing off-target side effects. In asthma, inflammation is present throughout the airways, including peripheral ones or small airways &lt;2 mm in diameter<sup><a href="#ref-38">38</a></sup>, and these airways contribute to both inflammation and airway resistance<sup><a href="#ref-39">39</a></sup>. Therefore, systems that more effectively deliver therapy throughout the airways, especially ICS, may be more effective. Preparations of extra-fine hydrofluoroalkanes (HFAs) deliver ICS particles &lt;2 μm (HFA-ciclesonide and HFA-beclomethasone) with lung deposition of &gt;50% compared to CFC fluticasone or dry powdered fluticasone where the size is &gt;2 μm in size and lung deposition is between 10 and 15%<sup><a href="#ref-40">40</a></sup>. In addition, a small-particle aerosol that remains suspended in the air for longer should provide an advantage for dis-coordinated patients by improving lung deposition of the drug and reducing the dependence on correct inhaler technique. With these advantages in mind, Hodgson <i>et al.</i><sup><a href="#ref-41">41</a></sup> set out to determine in 30 asthmatics with refractory eosinophilia if the addition of extra-fine ciclesonide to the usual ICS regime and/or regime of oral corticosteroids (OCS) would suppress airway eosinophils. They selected subjects with persistent airway eosinophilia (sputum eosinophils &gt;3% or peripheral blood eosinophils &gt;0.4 × 10<sup>9</sup>/ml) and demonstrated that a short course of prednisone 30 mg/day would normalize exhaled nitric oxide (&lt;25 ppB) and improve FEV1 and asthma control. They then added either ciclesonide 320 mcg/day or placebo to the usual ICS regime (median dose of beclomethasone equivalent 1600 mcg/day) or low-dose regular OCS (a third remained on OCS). Ciclesonide appeared to be better at maintaining sputum eosinophils &lt;3%, but this did not demonstrate significance until those subjects who had (against protocol) reduced their OCS were excluded; the median sputum eosinophils compared between the groups were 1.4% ciclesonide versus 4.5% controls, p=0.028.</p><p class="" id=d37704e556>A direct comparison was made of the use of ICS extra-fine ciclesonide (dose 160–320 mcg) with the use of fluticasone (500 mcg/day) in 1390 milder asthmatics aged 12–60 years<sup><a href="#ref-42">42</a></sup>. Despite the lower dose of ICS, the ciclesonide arm demonstrated fewer acute exacerbations, with an adjusted rate ratio of 0.59 (95% CI 0.47–0.73).</p><p class="" id=d37704e563>Finally, there was the example of applying technology to deliver corticosteroids to the airways more effectively. Vogelmeier <i>et al.</i><sup><a href="#ref-43">43</a></sup> tested the application of a new computer-controlled air compressor (AKITA) to deliver budesonide solution to a group (n=199) with severe, GINA step 5 asthma requiring regular OCS. There were four arms: air-interfaced culture (AIC) budesonide 1 mg, AIC budesonide 0.5 mg, budesonide 1 mg delivered by standard nebulizer, and placebo. In the run-in phase, subjects were able to have their OCS dose reduced by 50%. Following treatment, both AIC arms demonstrated improved FEV1 compared to standard nebulized budesonide and placebo, with the AIC 1 mg arm demonstrating a significant reduction in exacerbations at 7% compared to standard budesonide at 22% and placebo at 19%.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d37704e575>Biological agents and asthma</h2><p class="" id=d37704e578>Biologic agents represent a major innovation in the treatment of chronic immune-mediated disease and have led to important advances in the management of rheumatoid arthritis, inflammatory bowel disease, and, since the advent of omalizumab, severe asthma. Dupilumab is a monoclonal antibody that binds to the IL-4 receptor-α and has the ability to block the action of both IL-4 and IL-13. It has demonstrated promising efficacy in the treatment of allergic rhinitis and nasal polyposis, eczema, and asthma with elevated blood eosinophils<sup><a href="#ref-44">44</a></sup>. In their publication, however, Wenzel <i>et al.</i><sup><a href="#ref-45">45</a></sup> did not confine treatment to those with persistent eosinophilia but selected 729 subjects with persistent symptoms despite treatment with medium- to high-dose ICS and long-acting beta agonists (LABAs). Patients were randomly assigned (1:1:1:1:1) to receive subcutaneous dupilumab 200 mg or 300 mg every 2 weeks or every 4 weeks, or placebo, over a 24-week period. The primary endpoint was change from baseline at week 12 in FEV1, and subgroup analysis was done based on blood eosinophils &lt; or &gt; 300/μL. The best effect was seen with biweekly dosing and little difference was seen between 200 mg and 300 mg doses. The effect size appeared slightly greater in those with elevated blood eosinophils, but significant improvements were seen in all patients. The greatest change in FEV1 compared with placebo was observed at week 12 with doses every 2 weeks in the 300 mg group (mean change 0.39 L [SE 0.05]; mean difference 0.21 [95% CI 0.06–0.36; p=0.0063]) and in the 200 mg group (mean change 0.43 L [SE 0.05]; mean difference 0.26 [0.11–0.40; p=0.0008]) compared with placebo (0.18 L [SE 0.05]). These changes were sustained to week 24. In addition, subjects demonstrated reductions in annualized rates of exacerbation in the overall population (70–70.5%), the subgroup with at least 300 eosinophils/μL (71.2–80.7%), and the subgroup with fewer than 300 eosinophils/μL (59.9–67.6%). The most common adverse events with dupilumab compared with placebo were upper respiratory tract infections (33–41% versus 35%) and injection-site reactions (13–26% versus 13%). Dupilumab offers perhaps the most promise of any of the current biological agents proposed for managing severe asthma. It appears to have favorable effects on important co-morbidities such as chronic sinusitis, nasal polyposis, and atopic dermatitis. In comparison, omalizumab is confined to only those with atopic asthma, where an improvement in FEV1 has not been shown and the reduction in exacerbation rates is only 25%<sup><a href="#ref-46">46</a></sup>. Monoclonal antibodies to IL-5 appear to have their efficacy limited to those with at least 150 eosinophils/μL, and in these individuals the reduction in exacerbation rate is in the order of only 47%<sup><a href="#ref-46">46</a></sup>. In addition, the fact that dupilumab – an agent that blocks the classic type II immune IL-4/-13 pathway in asthma – demonstrated efficacy in those with and without eosinophilia raises the possibility that our ability to identify when type II immune mechanisms are active with biomarkers remains imperfectly understood.</p><p class="" id=d37704e599>A second-generation monoclonal antibody to IgE, ligelizumab, has been developed and this demonstrates significantly greater <i>in vitro</i> binding affinity than does omalizumab<sup><a href="#ref-47">47</a></sup>. In a small proof-of-concept trial, 37 mild atopic asthmatics were randomized to receive ligelizumab, omalizumab, or placebo<sup><a href="#ref-47">47</a></sup>. Ligelizumab attenuated the effect of allergen challenge threefold more effectively than did omalizumab and 16-fold better than did placebo. It also more effectively suppressed skin test reactivity to sensitized allergens, which peaked after 18 weeks of treatment.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d37704e616>Targeting non-type II immune responses in asthma</h2><p class="" id=d37704e619>Most of the emerging therapies for asthma target type II immune mechanisms. However, at best, abnormalities in type II immune responses occur in only 50% of adults with allergic asthma. As new therapeutics start to bring type II immune-mediated asthma under control, researchers need to focus greater efforts on defining the mechanisms of disease in these other patients to realize better outcomes<sup><a href="#ref-48">48</a></sup>.</p><p class="" id=d37704e626>One important group with difficult-to-control asthma is older adults with obesity. Obesity is common in asthma and is associated with systemic inflammation and metabolic dysfunction, such as insulin resistance and hypertension. The presence of low-grade systemic inflammation occurs in only a subgroup with obesity, but it predicts the presence of these other important comorbidities that make up the metabolic syndrome<sup><a href="#ref-49">49</a></sup>. Researchers for the Severe Asthma Research Program and the University of California San Francisco combined data and an analysis of stored samples from 387 well-characterized subjects with severe asthma and 249 milder asthmatics as well as 93 healthy controls. Using a cutoff level of serum IL-6 at 3.1 pg/mL to define systemic inflammation, they divided the subjects into IL-6 high and low groups<sup><a href="#ref-50">50</a></sup>. The IL-6 high group was more common in the cohort with severe asthma and had lower FEV1, worsened asthma control, and more frequent exacerbations. They were more likely to be female, have a higher body mass index (BMI), and be more were hypertensive. However, high IL-6 was not related to either blood eosinophils or exhaled nitric oxide. While 86% of those with high IL-6 were obese, only 62% of obese asthmatics had elevated serum IL-6. Using a BMI of &gt;30 as a cutoff, those with elevated IL-6 and obesity had the lowest FEV1, had more exacerbations, and were more likely to have features of metabolic syndrome. This work certainly identifies serum IL-6 as an important biomarker in severe asthma and links it to obesity and metabolic syndrome.</p><p class="" id=d37704e637>In light of the recent evidence of serum IL-6 playing a role in difficult asthma and metabolic syndrome, a small trial by Franca-Pinta <i>et al.</i><sup><a href="#ref-51">51</a></sup> offers further insight and strategies to intervene. The authors took 58 asthmatics and recruited them to undergo a regime of aerobic exercise training or a sham intervention for 12 weeks. At the end of 12 weeks, the exercise group demonstrated reduced bronchial hyper-reactivity as well as a reduction in serum IL-6. Interestingly, though, there was no change in sputum cell counts or exhaled nitric oxide.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d37704e650>The mechanisms of disease in severe asthma differ from mild to moderate disease</h2><p class="" id=d37704e653>Severe asthma is known to behave in a clinically distinct manner to mild and moderate disease, which is characterized by type II immune pathology and corticosteroid responsiveness. In contrast, severe asthma is inherently corticosteroid resistant and appears to be associated with more complex airway pathology<sup><a href="#ref-52">52</a>,<a href="#ref-53">53</a></sup>. Further light has been shed on these mechanisms by Raundhal <i>et al.</i><sup><a href="#ref-54">54</a></sup>. They examined bronchial lavage from severe and mild/moderate asthma, finding that the majority of T cells were CD4. In severe asthma, there were more CD4 cells that expressed IFN-γ, TH17 cells were also more numerous, while both groups had low numbers of TH2 cells. The severe asthma immune response was then modeled in mice to determine the functional significance of a higher TH1 response. They found that it was IFN-γ, and not IL-17, that mediated bronchial reactivity. However, IL-17 led to neutrophil accumulation in the airways. Both in humans and in mice, the expression of secretory leukocyte protease inhibitor (SLPI) was downregulated in epithelial cells as a consequence of IFN-γ exposure. As SLPI can inhibit bronchial reactivity, this may provide an explanation for the poor lung function seen in severe asthma. When SLPI expression was enhanced in the mice, this reduced bronchial reactivity and augmented the response to corticosteroids. This work paints a very complex picture of severe asthma, where non-type II immune pathology and IFN-γ/SLPI drive bronchial reactivity through as-yet-unknown mechanisms and IL-17 may play a secondary role in recruiting neutrophils but where the presence of TH2 cells, albeit in low numbers, could still be important.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d37704e672>Conclusions</h2><p class="" id=d37704e675>The last 12 months have once again seen significant activity in the area of asthma research, resulting in improved understanding and new insights with regard to its management. Important research is now emerging that demonstrates crucial links between the innate immune response and traditional type II acquired immune responses in asthma. We would predict this to be one of the next areas to emerge where the development of targeted therapies could lead to important new treatments. As this area is crucial in the pathogenesis of asthma in childhood and the interaction of viral infection and allergic sensitization, it may hold hope for the development of treatments that will specifically target acute asthma and potentially influence the progression of early childhood disease.</p><p class="" id=d37704e678>Clinical trials of biological agents are likely to continue to evolve, though at this stage they are still the most efficacious in those with severe disease and those with either allergic disease or dysregulated type II immune responses. It is possible that in the near future, if they are applied in their current forms to early disease, they may modify the disease course in asthma.</p><p class="" id=d37704e681>A major deficiency, however, remains in the lack of understanding of the mechanisms of disease that exist in those asthmatics with non-type II immune responses. They make up an important and growing body of asthmatics with a high disease burden. They are associated with other chronic diseases, where the processes underlying asthma may overlap and impact on these processes as well. They are known to respond relatively poorly to current asthma treatments, and while the mechanisms driving disease in these cases remain unclear and until a better understanding of these processes are made, more effective treatments will remain elusive.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d37704e1 class=n-a></a><h2 class=main-title id=d37898>Competing interests</h2><p class=metadata-entry><a name=d37704e90 class=n-a></a><p id=d37704e92> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d37704e1 class=n-a></a><h2 class=main-title id=d37900>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d37704e688 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d38081>References</h2><div class="section ref-list"><a name=d37704e688 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d37704e695 class=n-a></a>Johnston SL, Pattemore PK, Sanderson G, <i> et al.</i>: The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. <i>Am J Respir Crit Care Med.</i> 1996; <b>154</b>(3 Pt 1): 654–60. <a target=xrefwindow id=d37704e706 href="http://www.ncbi.nlm.nih.gov/pubmed/8810601">PubMed Abstract </a> | <a target=xrefwindow id=d37704e709 href="http://dx.doi.org/10.1164/ajrccm.154.3.8810601">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d37704e718 class=n-a></a>Wark PA, Johnston SL, Moric I, <i> et al.</i>: Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. <i>Eur Respir J.</i> 2002; <b>19</b>(1): 68–75. <a target=xrefwindow id=d37704e729 href="http://www.ncbi.nlm.nih.gov/pubmed/11852895">PubMed Abstract </a> | <a target=xrefwindow id=d37704e732 href="http://dx.doi.org/10.1183/09031936.02.00226302">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d37704e741 class=n-a></a>Hershenson MB: Rhinovirus-Induced Exacerbations of Asthma and COPD. <i>Scientifica (Cairo).</i> 2013; <b>2013</b>: 405876. <a target=xrefwindow id=d37704e749 href="http://www.ncbi.nlm.nih.gov/pubmed/24278777">PubMed Abstract </a> | <a target=xrefwindow id=d37704e752 href="http://dx.doi.org/10.1155/2013/405876">Publisher Full Text </a> | <a target=xrefwindow id=d37704e755 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3820304">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d37704e764 class=n-a></a>Isaacs A, Lindenmann J: Virus interference. I. The interferon. <i>Proc R Soc Lond B Biol Sci.</i> 1957; <b>147</b>(927): 258–67. <a target=xrefwindow id=d37704e772 href="http://www.ncbi.nlm.nih.gov/pubmed/13465720">PubMed Abstract </a> | <a target=xrefwindow id=d37704e775 href="http://dx.doi.org/10.1098/rspb.1957.0048">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d37704e784 class=n-a></a>Contoli M, Message SD, Laza-Stanca V, <i> et al.</i>: Role of deficient type III interferon-lambda production in asthma exacerbations. <i>Nat Med.</i> 2006; <b>12</b>(9): 1023–6. <a target=xrefwindow id=d37704e795 href="http://www.ncbi.nlm.nih.gov/pubmed/16906156">PubMed Abstract </a> | <a target=xrefwindow id=d37704e798 href="http://dx.doi.org/10.1038/nm1462">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d37704e808 class=n-a></a>Wark PA, Johnston SL, Bucchieri F, <i> et al.</i>: Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. <i>J Exp Med.</i> 2005; <b>201</b>(6): 937–47. <a target=xrefwindow id=d37704e819 href="http://www.ncbi.nlm.nih.gov/pubmed/15781584">PubMed Abstract </a> | <a target=xrefwindow id=d37704e822 href="http://dx.doi.org/10.1084/jem.20041901">Publisher Full Text </a> | <a target=xrefwindow id=d37704e826 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2213100">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/8897956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e835 class=n-a></a>Cakebread JA, Xu Y, Grainge C, <i> et al.</i>: Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus. <i>J Allergy Clin Immunol.</i> 2011; <b>127</b>(5): 1148–54.e9. <a target=xrefwindow id=d37704e846 href="http://www.ncbi.nlm.nih.gov/pubmed/21329968">PubMed Abstract </a> | <a target=xrefwindow id=d37704e849 href="http://dx.doi.org/10.1016/j.jaci.2011.01.023">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/8897956">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d37704e862 class=n-a></a>Parsons KS, Hsu AC, Wark PA: TLR3 and MDA5 signalling, although not expression, is impaired in asthmatic epithelial cells in response to rhinovirus infection. <i>Clin Exp Allergy.</i> 2014; <b>44</b>(1): 91–101. <a target=xrefwindow id=d37704e870 href="http://www.ncbi.nlm.nih.gov/pubmed/24131248">PubMed Abstract </a> | <a target=xrefwindow id=d37704e873 href="http://dx.doi.org/10.1111/cea.12218">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d37704e882 class=n-a></a>Baraldo S, Contoli M, Bazzan E, <i> et al.</i>: Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. <i>J Allergy Clin Immunol.</i> 2012; <b>130</b>(6): 1307–14. <a target=xrefwindow id=d37704e893 href="http://www.ncbi.nlm.nih.gov/pubmed/22981791">PubMed Abstract </a> | <a target=xrefwindow id=d37704e896 href="http://dx.doi.org/10.1016/j.jaci.2012.08.005">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d37704e905 class=n-a></a>Lopez-Souza N, Favoreto S, Wong H, <i> et al.</i>: <i>In vitro</i> susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. <i>J Allergy Clin Immunol.</i> 2009; <b>123</b>(6): 1384–90.e2. <a target=xrefwindow id=d37704e919 href="http://www.ncbi.nlm.nih.gov/pubmed/19428098">PubMed Abstract </a> | <a target=xrefwindow id=d37704e923 href="http://dx.doi.org/10.1016/j.jaci.2009.03.010">Publisher Full Text </a> | <a target=xrefwindow id=d37704e926 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2744461">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d37704e935 class=n-a></a>Bochkov YA, Hanson KM, Keles S, <i> et al.</i>: Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. <i>Mucosal Immunol.</i> 2010; <b>3</b>(1): 69–80. <a target=xrefwindow id=d37704e946 href="http://www.ncbi.nlm.nih.gov/pubmed/19710636">PubMed Abstract </a> | <a target=xrefwindow id=d37704e949 href="http://dx.doi.org/10.1038/mi.2009.109">Publisher Full Text </a> | <a target=xrefwindow id=d37704e953 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2884103">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726388361"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e963 class=n-a></a>Kicic A, Stevens PT, Sutanto EN, <i> et al.</i>: Impaired airway epithelial cell responses from children with asthma to rhinoviral infection. <i>Clin Exp Allergy.</i> 2016. <a target=xrefwindow id=d37704e971 href="http://www.ncbi.nlm.nih.gov/pubmed/27238549">PubMed Abstract </a> | <a target=xrefwindow id=d37704e974 href="http://dx.doi.org/10.1111/cea.12767">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726388361">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726211911"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e987 class=n-a></a>Simpson JL, Carroll M, Yang IA, <i> et al.</i>: Reduced Antiviral Interferon Production in Poorly Controlled Asthma Is Associated With Neutrophilic Inflammation and High-Dose Inhaled Corticosteroids. <i>Chest.</i> 2016; <b>149</b>(3): 704–13. <a target=xrefwindow id=d37704e998 href="http://www.ncbi.nlm.nih.gov/pubmed/26836898">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1001 href="http://dx.doi.org/10.1016/j.chest.2015.12.018">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726211911">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725430177"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1014 class=n-a></a>Contoli M, Ito K, Padovani A, <i> et al.</i>: Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells. <i>Allergy.</i> 2015; <b>70</b>(8): 910–20. <a target=xrefwindow id=d37704e1025 href="http://www.ncbi.nlm.nih.gov/pubmed/25858686">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1028 href="http://dx.doi.org/10.1111/all.12627">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725430177">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d37704e1041 class=n-a></a>Moriwaki A, Matsumoto K, Matsunaga Y, <i> et al.</i>: IL-13 suppresses double-stranded RNA-induced IFN-λ production in lung cells. <i>Biochem Biophys Res Commun.</i> 2011; <b>404</b>(4): 922–7. <a target=xrefwindow id=d37704e1052 href="http://www.ncbi.nlm.nih.gov/pubmed/21184733">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1055 href="http://dx.doi.org/10.1016/j.bbrc.2010.12.082">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726642177"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1064 class=n-a></a>Herbert C, Zeng QX, Shanmugasundaram R, <i> et al.</i>: Response of airway epithelial cells to double-stranded RNA in an allergic environment. <i>Transl Respir Med.</i> 2014; <b>2</b>(1): 11. <a target=xrefwindow id=d37704e1075 href="http://www.ncbi.nlm.nih.gov/pubmed/25264520">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1078 href="http://dx.doi.org/10.1186/s40247-014-0011-6">Publisher Full Text </a> | <a target=xrefwindow id=d37704e1082 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4173067">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726642177">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725330269"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1095 class=n-a></a>Gielen V, Sykes A, Zhu J, <i> et al.</i>: Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons. <i>J Allergy Clin Immunol.</i> 2015; <b>136</b>(1): 177–188.e11. <a target=xrefwindow id=d37704e1106 href="http://www.ncbi.nlm.nih.gov/pubmed/25630941">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1109 href="http://dx.doi.org/10.1016/j.jaci.2014.11.039">Publisher Full Text </a> | <a target=xrefwindow id=d37704e1113 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4541718">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725330269">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/724611994"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1127 class=n-a></a>Jackson DJ, Makrinioti H, Rana BM, <i> et al.</i>: IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations <i>in vivo</i>. <i>Am J Respir Crit Care Med.</i> 2014; <b>190</b>(12): 1373–82. <a target=xrefwindow id=d37704e1141 href="http://www.ncbi.nlm.nih.gov/pubmed/25350863">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1145 href="http://dx.doi.org/10.1164/rccm.201406-1039OC">Publisher Full Text </a> | <a target=xrefwindow id=d37704e1148 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4299647">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/724611994">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726066367"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1161 class=n-a></a>Porsbjerg C, Baines K, Gibson P, <i> et al.</i>: IL-33 is related to innate immune activation and sensitization to HDM in mild steroid-free asthma. <i>Clin Exp Allergy.</i> 2016; <b>46</b>(4): 564–74. <a target=xrefwindow id=d37704e1172 href="http://www.ncbi.nlm.nih.gov/pubmed/26748611">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1175 href="http://dx.doi.org/10.1111/cea.12702">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726066367">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726427958"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1188 class=n-a></a>Tashiro H, Takahashi K, Hayashi S, <i> et al.</i>: Interleukin-33 from Monocytes Recruited to the Lung Contributes to House Dust Mite-Induced Airway Inflammation in a Mouse Model. <i>PLoS One.</i> 2016; <b>11</b>(6): e0157571. <a target=xrefwindow id=d37704e1199 href="http://www.ncbi.nlm.nih.gov/pubmed/27310495">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1202 href="http://dx.doi.org/10.1371/journal.pone.0157571">Publisher Full Text </a> | <a target=xrefwindow id=d37704e1206 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4910993">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726427958">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d37704e1219 class=n-a></a>Scanlon ST, McKenzie AN: Type 2 innate lymphoid cells: new players in asthma and allergy. <i>Curr Opin Immunol.</i> 2012; <b>24</b>(6): 707–12. <a target=xrefwindow id=d37704e1227 href="http://www.ncbi.nlm.nih.gov/pubmed/22985480">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1230 href="http://dx.doi.org/10.1016/j.coi.2012.08.009">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725901658"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1239 class=n-a></a>Halim TY, Hwang YY, Scanlon ST, <i> et al.</i>: Group 2 innate lymphoid cells license dendritic cells to potentiate memory T<sub>H</sub>2 cell responses. <i>Nat Immunol.</i> 2016; <b>17</b>(1): 57–64. <a target=xrefwindow id=d37704e1253 href="http://www.ncbi.nlm.nih.gov/pubmed/26523868">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1257 href="http://dx.doi.org/10.1038/ni.3294">Publisher Full Text </a> | <a target=xrefwindow id=d37704e1260 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4685755">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725901658">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718113131"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1273 class=n-a></a>Nussbaum JC, Van Dyken SJ, von Moltke J, <i> et al.</i>: Type 2 innate lymphoid cells control eosinophil homeostasis. <i>Nature.</i> 2013; <b>502</b>(7470): 245–8. <a target=xrefwindow id=d37704e1284 href="http://www.ncbi.nlm.nih.gov/pubmed/24037376">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1287 href="http://dx.doi.org/10.1038/nature12526">Publisher Full Text </a> | <a target=xrefwindow id=d37704e1291 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3795960">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718113131">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725957336"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1305 class=n-a></a>Duerr CU, McCarthy CD, Mindt BC, <i> et al.</i>: Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells. <i>Nat Immunol.</i> 2016; <b>17</b>(1): 65–75. <a target=xrefwindow id=d37704e1316 href="http://www.ncbi.nlm.nih.gov/pubmed/26595887">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1319 href="http://dx.doi.org/10.1038/ni.3308">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725957336">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726394129"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1332 class=n-a></a>Lynch JP, Werder RB, Simpson J, <i> et al.</i>: Aeroallergen-induced IL-33 predisposes to respiratory virus-induced asthma by dampening antiviral immunity. <i>J Allergy Clin Immunol.</i> 2016; pii: S0091-6749(16)30150-6. <a target=xrefwindow id=d37704e1340 href="http://www.ncbi.nlm.nih.gov/pubmed/27236500">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1343 href="http://dx.doi.org/10.1016/j.jaci.2016.02.039">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726394129">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726431092"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1356 class=n-a></a>Jia Y, Fang X, Zhu X, <i> et al.</i>: IL-13<sup>+</sup> Type 2 Innate Lymphoid Cells Correlate with Asthma Control Status and Treatment Response. <i>Am J Respir Cell Mol Biol.</i> 2016. <a target=xrefwindow id=d37704e1367 href="http://www.ncbi.nlm.nih.gov/pubmed/27314535">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1370 href="http://dx.doi.org/10.1165/rcmb.2016-0099OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726431092">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725944463"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1383 class=n-a></a>Zissler UM, Chaker AM, Effner R, <i> et al.</i>: Interleukin-4 and interferon-γ orchestrate an epithelial polarization in the airways. <i>Mucosal Immunol.</i> 2016; <b>9</b>(4): 917–26. <a target=xrefwindow id=d37704e1394 href="http://www.ncbi.nlm.nih.gov/pubmed/26577568">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1397 href="http://dx.doi.org/10.1038/mi.2015.110">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725944463">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726105974"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1410 class=n-a></a>Chawes BL, Bønnelykke K, Stokholm J, <i> et al.</i>: Effect of Vitamin D<sub>3</sub> Supplementation During Pregnancy on Risk of Persistent Wheeze in the Offspring: A Randomized Clinical Trial. <i>JAMA.</i> 2016; <b>315</b>(4): 353–61. <a target=xrefwindow id=d37704e1424 href="http://www.ncbi.nlm.nih.gov/pubmed/26813208">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1428 href="http://dx.doi.org/10.1001/jama.2015.18318">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726105974">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726105973"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1441 class=n-a></a>Litonjua AA, Carey VJ, Laranjo N, <i> et al.</i>: Effect of Prenatal Supplementation With Vitamin D on Asthma or Recurrent Wheezing in Offspring by Age 3 Years: The VDAART Randomized Clinical Trial. <i>JAMA.</i> 2016; <b>315</b>(4): 362–70. <a target=xrefwindow id=d37704e1452 href="http://www.ncbi.nlm.nih.gov/pubmed/26813209">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1455 href="http://dx.doi.org/10.1001/jama.2015.18589">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726105973">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d37704e1469 class=n-a></a>Almqvist C, Worm M, Leynaert B: Impact of gender on asthma in childhood and adolescence: a GA<sup>2</sup>LEN review. <i>Allergy.</i> 2008; <b>63</b>(1): 47–57. <a target=xrefwindow id=d37704e1480 href="http://www.ncbi.nlm.nih.gov/pubmed/17822448">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1483 href="http://dx.doi.org/10.1111/j.1398-9995.2007.01524.x">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d37704e1492 class=n-a></a>Tse SM, Rifas-Shiman SL, Coull BA, <i> et al.</i>: Sex-specific risk factors for childhood wheeze and longitudinal phenotypes of wheeze. <i>J Allergy Clin Immunol.</i> 2016; pii: S0091-6749(16)30188-9. <a target=xrefwindow id=d37704e1500 href="http://www.ncbi.nlm.nih.gov/pubmed/27246527">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1503 href="http://dx.doi.org/10.1016/j.jaci.2016.04.005">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726313821"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1512 class=n-a></a>Virchow JC, Backer V, Kuna P, <i> et al.</i>: Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial. <i>JAMA.</i> 2016; <b>315</b>(16): 1715–25. <a target=xrefwindow id=d37704e1523 href="http://www.ncbi.nlm.nih.gov/pubmed/27115376">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1526 href="http://dx.doi.org/10.1001/jama.2016.3964">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726313821">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d37704e1539 class=n-a></a>Teach SJ, Gergen PJ, Szefler SJ, <i> et al.</i>: Seasonal risk factors for asthma exacerbations among inner-city children. <i>J Allergy Clin Immunol.</i> 2015; <b>135</b>(6): 1465–73.e5. <a target=xrefwindow id=d37704e1550 href="http://www.ncbi.nlm.nih.gov/pubmed/25794658">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1553 href="http://dx.doi.org/10.1016/j.jaci.2014.12.1942">Publisher Full Text </a> | <a target=xrefwindow id=d37704e1557 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4461505">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725893596"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1566 class=n-a></a>Teach SJ, Gill MA, Togias A, <i> et al.</i>: Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. <i>J Allergy Clin Immunol.</i> 2015; <b>136</b>(6): 1476–85. <a target=xrefwindow id=d37704e1577 href="http://www.ncbi.nlm.nih.gov/pubmed/26518090">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1580 href="http://dx.doi.org/10.1016/j.jaci.2015.09.008">Publisher Full Text </a> | <a target=xrefwindow id=d37704e1584 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4679705">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725893596">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d37704e1597 class=n-a></a>Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. <i>N Engl J Med.</i> 2000; <b>343</b>(15): 1054–63. <a target=xrefwindow id=d37704e1605 href="http://www.ncbi.nlm.nih.gov/pubmed/11027739">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1608 href="http://dx.doi.org/10.1056/NEJM200010123431501">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726346797"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1618 class=n-a></a>McGeachie MJ, Yates KP, Zhou X, <i> et al.</i>: Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. <i>N Engl J Med.</i> 2016; <b>374</b>(19): 1842–52. <a target=xrefwindow id=d37704e1629 href="http://www.ncbi.nlm.nih.gov/pubmed/27168434">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1632 href="http://dx.doi.org/10.1056/NEJMoa1513737">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726346797">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d37704e1645 class=n-a></a>Speizer FE, Tager IB: Epidemiology of chronic mucus hypersecretion and obstructive airways disease. <i>Epidemiol Rev.</i> 1979; <b>1</b>: 124–42. <a target=xrefwindow id=d37704e1653 href="http://www.ncbi.nlm.nih.gov/pubmed/398264">PubMed Abstract </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d37704e1662 class=n-a></a>Hamid Q: Pathogenesis of small airways in asthma. <i>Respiration.</i> 2012; <b>84</b>(1): 4–11. <a target=xrefwindow id=d37704e1670 href="http://www.ncbi.nlm.nih.gov/pubmed/22759947">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1673 href="http://dx.doi.org/10.1159/000339550">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d37704e1682 class=n-a></a>Contoli M, Bousquet J, Fabbri LM, <i> et al.</i>: The small airways and distal lung compartment in asthma and COPD: a time for reappraisal. <i>Allergy.</i> 2010; <b>65</b>(2): 141–51. <a target=xrefwindow id=d37704e1693 href="http://www.ncbi.nlm.nih.gov/pubmed/19909298">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1696 href="http://dx.doi.org/10.1111/j.1398-9995.2009.02242.x">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d37704e1705 class=n-a></a>Leach C, Colice GL, Luskin A: Particle size of inhaled corticosteroids: does it matter? <i>J Allergy Clin Immunol.</i> 2009; <b>124</b>(6 Suppl): S88–93. <a target=xrefwindow id=d37704e1713 href="http://www.ncbi.nlm.nih.gov/pubmed/19962042">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1716 href="http://dx.doi.org/10.1016/j.jaci.2009.09.050">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725430093"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1725 class=n-a></a>Hodgson D, Anderson J, Reynolds C, <i> et al.</i>: A randomised controlled trial of small particle inhaled steroids in refractory eosinophilic asthma (SPIRA). <i>Thorax.</i> 2015; <b>70</b>(6): 559–65. <a target=xrefwindow id=d37704e1736 href="http://www.ncbi.nlm.nih.gov/pubmed/25858909">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1739 href="http://dx.doi.org/10.1136/thoraxjnl-2014-206481">Publisher Full Text </a> | <a target=xrefwindow id=d37704e1743 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4453493">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725430093">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726642273"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1757 class=n-a></a>van der Molen T, Postma DS, Martin RJ, <i> et al.</i>: Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands. <i>BMC Pulm Med.</i> 2016; <b>16</b>(1): 80. <a target=xrefwindow id=d37704e1768 href="http://www.ncbi.nlm.nih.gov/pubmed/27184175">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1771 href="http://dx.doi.org/10.1186/s12890-016-0234-0">Publisher Full Text </a> | <a target=xrefwindow id=d37704e1775 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4869182">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726642273">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726642285"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1788 class=n-a></a>Vogelmeier C, Kardos P, Hofmann T, <i> et al.</i>: Nebulised budesonide using a novel device in patients with oral steroid-dependent asthma. <i>Eur Respir J.</i> 2015; <b>45</b>(5): 1273–82. <a target=xrefwindow id=d37704e1799 href="http://www.ncbi.nlm.nih.gov/pubmed/25504995">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1802 href="http://dx.doi.org/10.1183/09031936.00152014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726642285">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718011925"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1815 class=n-a></a>Wenzel S, Ford L, Pearlman D, <i> et al.</i>: Dupilumab in persistent asthma with elevated eosinophil levels. <i>N Engl J Med.</i> 2013; <b>368</b>(26): 2455–66. <a target=xrefwindow id=d37704e1826 href="http://www.ncbi.nlm.nih.gov/pubmed/23688323">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1829 href="http://dx.doi.org/10.1056/NEJMoa1304048">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718011925">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726323110"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1842 class=n-a></a>Wenzel S, Castro M, Corren J, <i> et al.</i>: Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β<sub>2</sub> agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. <i>Lancet.</i> 2016; <b>388</b>(10039): 31–44. <a target=xrefwindow id=d37704e1856 href="http://www.ncbi.nlm.nih.gov/pubmed/27130691">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1860 href="http://dx.doi.org/10.1016/S0140-6736(16)30307-5">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726323110">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725490590"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1873 class=n-a></a>Rodrigo GJ, Neffen H: Systematic review on the use of omalizumab for the treatment of asthmatic children and adolescents. <i>Pediatr Allergy Immunol.</i> 2015; <b>26</b>(6): 551–6. <a target=xrefwindow id=d37704e1881 href="http://www.ncbi.nlm.nih.gov/pubmed/25963882">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1884 href="http://dx.doi.org/10.1111/pai.12405">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725490590">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d37704e1897 class=n-a></a>Gauvreau GM, Arm JP, Boulet LP, <i> et al.</i>: Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses. <i>J Allergy Clin Immunol.</i> 2016; pii: S0091-6749(16)30021-5. <a target=xrefwindow id=d37704e1905 href="http://www.ncbi.nlm.nih.gov/pubmed/27185571">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1908 href="http://dx.doi.org/10.1016/j.jaci.2016.02.027">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d37704e1918 class=n-a></a>Wenzel SE: Emergence of Biomolecular Pathways to Define Novel Asthma Phenotypes. Type-2 Immunity and Beyond. <i>Am J Respir Cell Mol Biol.</i> 2016; <b>55</b>(1): 1–4. <a target=xrefwindow id=d37704e1926 href="http://www.ncbi.nlm.nih.gov/pubmed/27164162">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1929 href="http://dx.doi.org/10.1165/rcmb.2016-0141PS">Publisher Full Text </a> | <a target=xrefwindow id=d37704e1932 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4942211">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d37704e1941 class=n-a></a>Lumeng CN, Saltiel AR: Inflammatory links between obesity and metabolic disease. <i>J Clin Invest.</i> 2011; <b>121</b>(6): 2111–7. <a target=xrefwindow id=d37704e1949 href="http://www.ncbi.nlm.nih.gov/pubmed/21633179">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1952 href="http://dx.doi.org/10.1172/JCI57132">Publisher Full Text </a> | <a target=xrefwindow id=d37704e1955 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3104776">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726414014"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1964 class=n-a></a>Peters MC, McGrath KW, Hawkins GA, <i> et al.</i>: Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. <i>Lancet Respir Med.</i> 2016; <b>4</b>(7): 574–84. <a target=xrefwindow id=d37704e1975 href="http://www.ncbi.nlm.nih.gov/pubmed/27283230">PubMed Abstract </a> | <a target=xrefwindow id=d37704e1978 href="http://dx.doi.org/10.1016/S2213-2600(16)30048-0">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726414014">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725551886"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e1991 class=n-a></a>França-Pinto A, Mendes FA, de Carvalho-Pinto RM, <i> et al.</i>: Aerobic training decreases bronchial hyperresponsiveness and systemic inflammation in patients with moderate or severe asthma: a randomised controlled trial. <i>Thorax.</i> 2015; <b>70</b>(8): 732–9. <a target=xrefwindow id=d37704e2002 href="http://www.ncbi.nlm.nih.gov/pubmed/26063507">PubMed Abstract </a> | <a target=xrefwindow id=d37704e2005 href="http://dx.doi.org/10.1136/thoraxjnl-2014-206070">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725551886">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d37704e2018 class=n-a></a>Wenzel SE, Schwartz LB, Langmack EL, <i> et al.</i>: Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. <i>Am J Respir Crit Care Med.</i> 1999; <b>160</b>(3): 1001–8. <a target=xrefwindow id=d37704e2029 href="http://www.ncbi.nlm.nih.gov/pubmed/10471631">PubMed Abstract </a> | <a target=xrefwindow id=d37704e2032 href="http://dx.doi.org/10.1164/ajrccm.160.3.9812110">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d37704e2041 class=n-a></a>Shaw DE, Sousa AR, Fowler SJ, <i> et al.</i>: Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. <i>Eur Respir J.</i> 2015; <b>46</b>(5): 1308–21. <a target=xrefwindow id=d37704e2052 href="http://www.ncbi.nlm.nih.gov/pubmed/26357963">PubMed Abstract </a> | <a target=xrefwindow id=d37704e2055 href="http://dx.doi.org/10.1183/13993003.00779-2015">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725597718"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d37704e2065 class=n-a></a>Raundhal M, Morse C, Khare A, <i> et al.</i>: High IFN-γ and low SLPI mark severe asthma in mice and humans. <i>J Clin Invest.</i> 2015; <b>125</b>(8): 3037–50. <a target=xrefwindow id=d37704e2076 href="http://www.ncbi.nlm.nih.gov/pubmed/26121748">PubMed Abstract </a> | <a target=xrefwindow id=d37704e2079 href="http://dx.doi.org/10.1172/JCI80911">Publisher Full Text </a> | <a target=xrefwindow id=d37704e2083 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4563754">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725597718">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 23 Aug 2016</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/5-2052.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/5-2052.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Priority Research Centre for Healthy Lungs, University of Newcastle, Hunter Medical Research Institute, New Lambton, NSW, 2305, Australia<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/5-2052/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 23 Aug 2016, 5:2052 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.9236.1">https://doi.org/10.12688/f1000research.9236.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2016 Loo SL and Wark PAB. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=9940 data-id=9236 data-downloads="" data-views="" data-scholar="10.12688/f1000research.9236.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/5-2052/v1/pdf?article_uuid=4ea0b20c-b74f-4b99-8489-8a9f7b13f8e3" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.9236.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Loo SL and Wark PAB. Recent advances in understanding and managing asthma [version 1; peer review: 2 approved] <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):2052 (<a href="https://doi.org/10.12688/f1000research.9236.1" target=_blank>https://doi.org/10.12688/f1000research.9236.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=9236 id=mobile-track-article-signin-9236 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/9236?target=/articles/5-2052.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=9940 /> <input name=articleId type=hidden value=9236 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Sally E. Wenzel</strong>, Department of Medicine, University of Pittsburgh, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> <span class=approved-referee__co-referee> <strong>Marc Gauthier</strong>, Department of Medicine, University of Pittsburgh, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Stanley Szefler</strong>, Department of Pediatrics, University of Colorado School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 23 Aug 2016</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/5-2052.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/5-2052.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=13232-15840></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=16684-15841></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/5-2052/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>23 Aug 16</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Sally E. Wenzel</strong>, Department of Medicine, University of Pittsburgh, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> <p class=" u-mt--2 u-mb--1/2"><strong>Marc Gauthier</strong>, Department of Medicine, University of Pittsburgh, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Stanley Szefler</strong>, Department of Pediatrics, University of Colorado School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/5-2052.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/5-2052/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding and managing...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/5-2052/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/5-2052/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/5-2052/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Loo SL and Wark PAB');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/5-2052/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/5-2052",
            templates : {
                twitter : "Recent advances in understanding and managing asthma. Loo SL and Wark PAB, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/5-2052/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding and managing asthma", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding and managing asthma", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/9236/9940")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "9940");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "15840": 0,
                           "15841": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "cbf7d7ff-59f0-4c58-97b1-42dcfc3783ec";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-2052.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-2052.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-2052.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/5-2052.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/5-2052.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>